Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kemp

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
ERJ Open Research|April 24, 2019
Evaluation of a re-useable bronchoscopy biosimulator with ventilated lungsJustin L Garner, Stefan D Garner, Robin J Hardie, et al.
Lung|February 22, 2011
Progress toward optical biopsy: bringing the microscope to the patientRichard C Newton, Samuel V Kemp, Pallav L Shah, et al.
The Lancet. Respiratory Medicine|August 31, 2017
A rigid solution to a relapsing problemThomas G Charlton, Anand Devaraj, Athol Wells, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 11, 2025
Undetectable Serum Thyroglobulin in Patients with Differentiated Thyroid Cancer: Anti-Thyroglobulin Antibodies, Assay Limitation, or Other?Benjamin Andress, Sandra A Miller, Anthony D Maus, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2016
Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up StudyJustin Garner, Samuel V Kemp, Tudor P Toma, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2017
Putative Mechanisms of Action of Endobronchial CoilsAnastasios F Palamidas, Samuel V Kemp, Mali Shen, et al.
The European Respiratory Journal|October 16, 2010
Atelectasis and survival after bronchoscopic lung volume reduction for COPDN S Hopkinson, S V Kemp, T P Toma, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trialPallav L Shah, Zaid Zoumot, Suveer Singh, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2006
Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibitionD McKillop, S P Guy, M P Spence, et al.
Plos One|April 9, 2015
Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trialZaid Zoumot, Samuel V Kemp, Suveer Singh, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
ERJ Open Research|April 24, 2019
Evaluation of a re-useable bronchoscopy biosimulator with ventilated lungsJustin L Garner, Stefan D Garner, Robin J Hardie, et al.
Lung|February 22, 2011
Progress toward optical biopsy: bringing the microscope to the patientRichard C Newton, Samuel V Kemp, Pallav L Shah, et al.
The Lancet. Respiratory Medicine|August 31, 2017
A rigid solution to a relapsing problemThomas G Charlton, Anand Devaraj, Athol Wells, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 11, 2025
Undetectable Serum Thyroglobulin in Patients with Differentiated Thyroid Cancer: Anti-Thyroglobulin Antibodies, Assay Limitation, or Other?Benjamin Andress, Sandra A Miller, Anthony D Maus, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2016
Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up StudyJustin Garner, Samuel V Kemp, Tudor P Toma, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2017
Putative Mechanisms of Action of Endobronchial CoilsAnastasios F Palamidas, Samuel V Kemp, Mali Shen, et al.
The European Respiratory Journal|October 16, 2010
Atelectasis and survival after bronchoscopic lung volume reduction for COPDN S Hopkinson, S V Kemp, T P Toma, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trialPallav L Shah, Zaid Zoumot, Suveer Singh, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2006
Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibitionD McKillop, S P Guy, M P Spence, et al.
Plos One|April 9, 2015
Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trialZaid Zoumot, Samuel V Kemp, Suveer Singh, et al.
Pageof 11